Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn’s Disease Patients

BACKGROUND/AIMS: Information regarding the efficacy of early infliximab treatment in pediatric patients with Crohn’s disease (CD) is limited. We aimed to evaluate the impact of early combined immunosuppression on linear growth in pediatric patients with CD by performing step-up comparisons. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jaeyoung, Kang, Ben, Kim, Min-Ji, Sohn, Insuk, Lee, Hae Jeong, Choe, Yon Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945256/
https://www.ncbi.nlm.nih.gov/pubmed/29298460
http://dx.doi.org/10.5009/gnl17290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945256/
https://www.ncbi.nlm.nih.gov/pubmed/29298460
http://dx.doi.org/10.5009/gnl17290

Ejemplares similares